Skip to content
Home/Companies/Biotech/Ervimmune
ER

Ervimmune

Biotech·France·Active·4yr hold

Ervimmune is a microbiome / nutrition /... company, headquartered in France.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Ervimmune?

Ervimmune is currently owned by Seventure Partners through Health for Life Capital (2014 vintage), since 2022.

Hand-verified · updated 2026-04-21

Seventure Partners
Investor
Seventure Partners
Health for Life Capital · 2014 · VC

Key facts

HQFrance
SectorMicrobiome / Nutrition /...

More from Health for Life Capital

Other portfolio companies in the same fund.

Kainova Therapeutics
Active
HealthcareCanada· 2026
MaaT Pharma
Active
BiotechFrance· 2026
Microbiotica
Active
BiotechUK· 2026
Standing Ovation
Active
BiotechFrance· 2026
Sunrise
Active
MedTechBelgium· 2024
Cmbio –...
Active
BiotechDenmark· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings